Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2020-02-26 / J Cell Mol Med 2020 04;24(7):4286-4297Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
/in International Publications, Newcastle Disease Virus /von 2020-02-22 / Cancer Immunol. Immunother. 2020 Jun;69(6):1015-1027[The adjuvant killing effect of modulated electro-hyperthermia combined with chemotherapy on B16F10 melanoma cells]
/in Hyperthermia, International Publications, Malignant Melanoma /von 2020-02-21 / Magy Onkol 2021 Mar;65(1):71-77Immunotherapy in Malignant Pleural Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2020-02-21 / Front Oncol 2020;10:187Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients
/in Dendritic Cells, International Publications /von 2020-02-20 / Cancer Immunol. Immunother. 2020 Jul;69(7):1375-1387Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results
/in Colorectal Cancer, Hyperthermia, International Publications /von 2020-02-09 / Neoplasma 2020 May;67(3):677-683Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis.
/in Dendritic Cells, International Publications /von 2020-02-07 / J Clin Oncol 38, 2020 (suppl 5; abstr 63)Ehrung für bahnbrechende Entdeckung in der Immuntherapie für Prof. Shimon Sakaguchi
/in Externe Meldungen /von IOZK
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution